KIZLAITIENĖ , R.; GIEDRAITIENĖ , N.; SEREIKĖ , I.; LIUTKIENĖ , J.; LEŠČINSKIENĖ , L.; KAUBRYS , G. Recommendations for the treatment of multiple sclerosis with disease-modifying drugs during the COVID-19 pandemic. Neurologijos seminarai, [S. l.], v. 24, n. 2(84), p. 100–104, 2020. DOI: 10.29014/ns.2020.13. Disponível em: https://www.journals.vu.lt/neurologijos_seminarai/article/view/27741.. Acesso em: 18 jul. 2024.